In addition to superiority over FIT in sensitivity for both colorectal cancer and advanced precancerous lesions, the next-generation Cologuard test demonstrated 91% specificity. 1 The specificity ...

Next-generation Cologuard exhibited improved colorectal cancer specificity and sensitivity compared with results of the FDA registrational trial that led to approval of the noninvasive screening ...

The BeLPT has high specificity for identifying chronic beryllium disease but poor sensitivity in distinguishing it from sarcoidosis.

Human papillomavirus (HPV) testing on self-collected samples may increase coverage of cervical cancer screening, but previous studies have observed lower specificity of HPV testing in self- versus ...

Among 8,920 participants, the test sensitivity for detecting colorectal cancer was 94%, and 46% for detecting advanced adenomas, while specificity for no lesions on colonoscopy was 88%, reported ...

A cell-free DNA blood-based test detected colorectal cancer with a sensitivity of 83% and a specificity of 90% for advanced neoplasia in an average-risk population, according to new data published ...

WASHINGTON -- A blood-based test for the early detection of colorectal cancer (CRC) met its prespecified sensitivity and specificity endpoints, according to results from the PREEMPT CRC study ...

Estimation of sensitivity and specificity for diagnostic or screening tests usually requires independent confirmation of subjects as diseased or nondiseased using a gold standard. In practice, however ...

Conclusions Symptoms, the SAC and the m-BESS have poor test-retest reliability. Symptoms have reasonable sensitivity and specificity for concussion but are subjective. The 3-word SAC and m-BESS are ...

Next-generation Cologuard Test Demonstrates 94 Percent Sensitivity for Colorectal Cancer at 91 Percent Specificity, Raising the Bar in Non-invasive Screening ...